Greenhaven Road Investment Management, L.P. 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:44 pm Purchase |
2024-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
Greenhaven Road Investment Management, L.P. | 3,616,146 9.800% |
1,249,190![]() (+52.78%) |
Filing |
2025-02-14 4:44 pm Purchase |
2023-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
Greenhaven Road Investment Management, L.P. | 2,366,956 7.800% |
464,317![]() (+24.40%) |
Filing |
2023-06-30 2:46 pm Purchase |
2023-06-21 | 13G | Lifecore Biomedical, Inc. LFCR |
Greenhaven Road Investment Management, L.P. | 1,902,639 6.300% |
1,902,639![]() (New Position) |
Filing |